梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。

美港电讯12-17

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492963587?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-17 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492963587","market":"hk","top_or_hot":-1,"title":"梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。","media":"美港电讯","content":"<html><body><p>梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。</p></body></html>","source":"live_meigang","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">美港电讯</strong><span class=\"h-time small\">2024-12-17 22:31</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.ushknews.com/\">美港电讯</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK5011","symbol_name":"制药","start_time":0,"source_url":"https://www.ushknews.com/","article_id":"2492963587","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492963587","pubTimestamp":1734445896,"columns":[],"sourceInfo":{"source_id":"live_meigang","name":"美港电讯"},"weMediaInfo":null,"summary":"梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。","collect":0,"end_time":0,"defaultTopTitle":"ushknews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK5011":"制药","0O59.UK":"赛诺菲","BK4566":"资本集团","TEVA":"梯瓦制药","BK4584":"避孕概念","BK4557":"大麻股","BK4559":"巴菲特持仓","SNY":"赛诺菲安万特","BK4585":"ETF&股票定投概念","BK4596":"哈里斯概念","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股","BK4007":"制药"},"translate_title":"Teva Pharmaceuticals (TEVA.N) rose 21% at the U.S. open, its biggest gain since July 2022. The company previously announced the results of the trial of Duvakitug with Sanofi (SNY.O), which reached the primary endpoint of the treatment of ulcerative colitis and Crohn's disease.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"0O59.UK":1,"SNY":1,"TEVA":1},"content_text":"梯瓦制药(TEVA.N)在美国开盘时上涨21%，为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果，达到治疗溃疡性结肠炎和克罗恩病的主要终点。","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492963587"}